Biography:
Dr. Sarkar received her Ph.D. from Purdue University on Biological Engineering, where she worked on “biophysical and biomolecular approaches to assess cell signaling and cross talk in breast cancer cells”. She did her first post-doctoral research at National Cancer Institute (NCI/NIH), focusing on the tumor suppressor role of C/EBPδ. During her second post-doctoral research at M.D. Anderson Cancer Center with Dr. Sendurai Mani, she has focused on identification and characterization of a breast cancer stem cell marker (GD2). Dr. Sarkar gained extensive experience working with cancer cell lines as well as in vivo xenograft models. She is currently an Assistant Professor at Biology and a co-director of the Center for Statistical Bioinformatics.
Targeted immunotherapy to inhibit circadian-disruption induced aggressive tumorigenesis
The role of EMT in angiogenesis-mediated tumor progression